Castillo, Shara N.
HRN: 18-94-89 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/15/2022
12/22/2022
IV
500mg
Q8
Msaf
Waiting Final Action
12/16/2022
METRONIDAZOLE 500MG (TAB)
12/16/2022
12/23/2022
ORAL
500mg
TID
MSAF
Waiting Final Action